WCM Investment Management’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-483,425
Closed -$10.5M 187
2020
Q2
$10.5M Buy
483,425
+33,109
+7% +$758K 0.04% 67
2020
Q1
$10.4M Buy
450,316
+17,374
+4% +$505K 0.06% 55
2019
Q4
$14.3M Buy
432,942
+72,015
+20% +$2.31M 0.08% 54
2019
Q3
$11.5M Sell
360,927
-30,719
-8% -$895K 0.07% 49
2019
Q2
$10.1M Sell
391,646
-11,537
-3% -$294K 0.06% 53
2019
Q1
$10.2M Buy
403,183
+164,313
+69% +$4.9M 0.07% 53
2018
Q4
$8.13M Buy
238,870
+22,976
+11% +$747K 0.07% 45
2018
Q3
$7.7M Buy
215,894
+40,344
+23% +$1.42M 0.07% 44
2018
Q2
$6.06M Sell
175,550
-23,736
-12% -$832K 0.06% 45
2018
Q1
$6.71M Sell
199,286
-68,564
-26% -$2.17M 0.06% 46
2017
Q4
$10.2M Buy
267,850
+223,490
+504% +$8.92M 0.12% 43
2017
Q3
$1.66M Buy
44,360
+2,700
+6% +$95.3K 0.02% 68
2017
Q2
$1.55M Buy
41,660
+1,045
+3% +$37.8K 0.02% 66
2017
Q1
$1.59M Buy
40,615
+27,215
+203% +$1.02M 0.02% 92
2016
Q4
$466K Buy
+13,400
New +$526K 0.01% 156

Other funds holding NTUS

WCM Investment Management's NTUS Position: Q3 2020 in Review

WCM Investment Management sold out of Natus Medical Inc (NTUS) in Q3 2020, closing a stake of 483,425 shares — an estimated $10.5M sold.

WCM Investment Management first reported a position in NTUS in Q4 2016 and held it in 15 quarters. The position peaked at $14.3M in Q4 2019. 159 funds tracked by Wall St. Rank hold NTUS as of Q3 2020.

  • WCM Investment Management reported no remaining Natus Medical Inc position as of Q3 2020 after selling out during the quarter.
  • WCM Investment Management sold 483,425 Natus Medical Inc shares in Q3 2020, an estimated $10.5M.
  • WCM Investment Management first reported a position in Natus Medical Inc in Q4 2016 and held it in 15 quarters.
  • WCM Investment Management's Natus Medical Inc position peaked at $14.3M in Q4 2019.
  • 159 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2020.

Based on WCM Investment Management's 13F filing for Q3 2020, filed 6 Nov 2020.